Mukaltin (Mucaltin)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Similar drugsTo uncover
Dosage form: & nbsppills
Composition:

For one tablet:

Mucaltin extract dry

(althea medicinal herb extract dry with content the sum of polysaccharides is not less than 18% in terms of glucose)

50.0 mg

Excipients:

to obtain a tablet weighing 0.3 g

Sodium bicarbonate

87.0 mg

Wine acid

159.5 mg

Plasdon K-90

0.5 mg

Calcium stearate monohydrate (calcium stearic acid 1-water)

3.0 mg
Description:

Tablets from light gray to brownish-gray color, with impregnations, with a specific smell, round, flat-cylindrical, with a facet on both sides and risk from one side. The heterogeneity of the surface coloring of the tablets is allowed.

Pharmacotherapeutic group:Expectorant of plant origin
ATX: & nbsp
  • Expectorants
    • Pharmacodynamics:

    Mucaltin (althaea medicinal herb extract) contains a mixture polysaccharides. Has expectorant properties - due to reflex stimulation enhances the activity of the ciliated epithelium and peristalsis of respiratory bronchioles in combination with increased secretion bronchial glands.

    Indications:

    Acute and chronic diseases of the respiratory tract, accompanied by cough with hard-to-separate sputum high viscosity (including tracheobronchitis, obstructive bronchitis, bronchiectasis, pneumonia) - the composition of complex therapy.

    Contraindications:Hypersensitivity to the components of the drug; peptic ulcer of the stomach and duodenum, children under 12 years.
    Pregnancy and lactation:The use of the drug is indicated if the potential benefit to the mother exceeds the possible risk to the fetus and the baby. It is necessary to consult a doctor!
    Dosing and Administration:

    Inside.

    Adults and children over 12 years of age: 1-2 tablets 2-3 times a day before eating.

    The course of treatment is 7-14 days.

    Children can dissolve a tablet in 1/3 a glass of warm water.

    Side effects:

    Possible dyspeptic phenomena, allergic reactions.

    Overdose:

    To date, cases of overdose with the use of the drug has not been recorded.

    Interaction:

    Mucaltin can be prescribed concomitantly with other drugs used in the treatment of bronchopulmonary diseases.

    Mucaltin should not be used concomitantly with drugs containing codeine and other antitussive medicines, as this hinders the expectoration of diluted sputum.

    Effect on the ability to drive transp. cf.and fur:Does not affect.
    Form release / dosage:Tablets, 50 mg.
    Packaging:

    For 10 pieces in a contour non-jawed packaging made of paper packaging with a polymer coating. One or two contour non-jawed packages together with the instruction for use are placed in a pack of cardboard. Contour non-cellular packages are allowed together with an equal number of instructions for use in group packaging.

    For 30 pieces in cans of orange glass with a desiccant or without it, ukuporennye caps aluminum with perforation.

    For 30 pieces in cans of polymer with a shock absorber and a lid with a pull control of the first opening or in the cans of polymer with a barrier neck with or without a desiccant.

    Each jar or bottle together with the instruction for use is placed in a pack of cardboard.

    Storage conditions:

    Store in a dry place at a temperature not exceeding 20 ° C.

    Keep out of the reach of children.

    Shelf life:

    2 years.

    Do not use after the expiration date.

    Terms of leave from pharmacies:Without recipe
    Registration number:LP-001012
    Date of registration:18.10.2011 / 11.09.2012
    Expiration Date:Unlimited
    The owner of the registration certificate:MOSCOW PHARMACEUTICAL FACTORY, CJSC MOSCOW PHARMACEUTICAL FACTORY, CJSC Russia
    Manufacturer: & nbsp
    Information update date: & nbsp20.05.2018
    Illustrated instructions
      Instructions
      Up